The new law allows the Government to:
require that the owner travels with the pets, or within 5 days of the pets arriving.
Danny said: “As a vet, I've treated many dogs with cruelly cropped ears or docked tails, leaving them physically scarred and emotionally traumatised.
"Knowing this Bill will help us put a stop to this abuse and have a bigger impact on animal welfare than I could possibly have achieved in a lifetime treating individual animals, demonstrates how important this legislation will prove to be.
"Thanks to the support of organisations like the BVA and other animal welfare nonprofits, we got the Animal Welfare Bill through the Commons, through the Lords, and today passed into law."
The College says the findings address evidence gaps from previous research and highlight the importance of routine veterinary otoscopic ear checks.
Although previous research has suggested that lop-eared rabbits may be more susceptible, the researchers say it relied on small samples and retrospective clinical records or owner reports.
For this study, RVC Rabbit Welfare Research Assistants, Maria Jackson RVN and Michaela Betts MRCVS, examined 435 pedigree rabbits volunteered by British Rabbit Council (BRC) breeders.
Between October 2023 and February 2024, the team travelled to BRC shows and breeding studs to record each rabbit’s ear type, head shape, estimated adult bodyweight, age and other features before performing a structured otoscopic examination in which the outer ear, the diverticulum and the full length of the external ear canal were checked for signs of inflammation, narrowing, discharge or crusting.
By combining these observations with multivariable statistics, the team was able to compare ear health across 49 breeds and identify which conformations were most strongly associated with specific ear abnormalities.
The results showed that ear shape plays a central role in predisposing rabbits to hidden ear disease.
Lop-eared rabbits were more likely to show 9 of the 11 abnormalities assessed, including ear canal narrowing, abnormal colour, flaky and wet discharge, behavioural reactivity to ear examination, dermatological changes to the pinna and crusts in the diverticulum.
The shape of a rabbit’s head was also associated with the types of ear problems they were likely to develop, but not in a consistent manner.
Brachycephalic rabbits had narrower ear canals, while dolichocephalic rabbits were more likely to have crusts in the diverticulum.
Body size mattered too, with heavier rabbits more likely to show problems such as redness, narrowing, flaky discharge and traumatic pinna changes, as well as stronger behavioural reactions during examination.
Other physical and signalment factors showed mixed results, highlighting the complexity of ear health across breeds.
Maria said: “Our findings have once again shown that rabbits with lop ears are more likely to develop ear problems – specifically, signs of otitis externa – than rabbits with upright ears."
Dr Charlotte Burn, Associate Professor in Animal Welfare and Behaviour Science at the RVC, and senior author on the paper, said: “This is the first study to have directly and systematically examined rabbit ears outside a clinical context, and it confirms that the seemingly endearing shape of lop rabbits’ ears really do risk deeper ear disorders.
"Alongside the physical changes we observed, we documented rabbit behaviour, such as avoidance, shaking their heads and scratching at their ears, and found that the lop-eared rabbits reacted significantly more to having their ears examined than rabbits with ‘up’ ears.
"To me, this indicates that their ears were not only physically affected, but they also hurt more, highlighting the animal welfare burden of this hidden problem.”
References
Vidas Equine Insulin provides insulin levels in approximately 20 minutes, which the company says will help with the diagnosis and management of Equine Metabolic Syndrome (EMS), commonly associated with insulin dysregulation in horses.
Vidas Equine ACTH provides dysregulation level testing of the adrenocorticotropic (ACTH) hormone related to the development of Equine Cushing’s Disease (aka Pituitary Pars Intermedia Dysfunction - PPID) in about 45 minutes.
Pierre Rouppert, Global Veterinary Product Manager at bioMérieux, said: “Our new endocrinology tests, because of their rapidity and ease of use, will bring clinical value for veterinary practices, directly at the Point of Care.
"Equine Metabolic Syndrome and Cushing’s Disease are chronic conditions that often evade detection in their initial stages, making early testing crucial in achieving proper management and animal care.”
David Smart, Global Veterinary Business Developer at bioMérieux, said: “This dedicated equine immunoassay test for insulin and ACTH represents a transformative step forward in animal care.
"Veterinary practitioners will be able to achieve fast, reliable and cost-effective laboratory grade results that can aid early detection and subsequent diagnosis for two prolific and debilitating medical conditions in horses.
"The fast and accurate results from these two new tests will allow quicker clinical decisions that will ultimately help more horses receive an improved standard of care and reassure horse owners.”
https://www.biomerieux.com/corp/en/our-offer/clinical-products/vidas-equine-insulin.html
The charity says it is facing serious financial pressures, with the cost of caring for rescued animals having increased by £17M over the last 5 years.
Meanwhile, claims for emergency treatments payments have dropped by 87% in the last two years because of a greater awareness by vets of their responsibilities under the RCVS Code in providing treatment to injured wildlife and stray animals.
Rebecca Ashman, the RSPCA’s Head Vet for Operations, Partnerships and Prevention, said: "Thanks to this, and better understanding of the role and remit of the RSPCA, we have been able to focus our charity resources on managing cases of cruelty and neglect."
She added: “The RSPCA has always worked closely with the veterinary professions and we are very grateful for the ongoing support of practices with our work.
"Colleagues will be aware that we have increasingly needed to focus on our core work of rescuing and rehabilitating neglected and cruelly treated animals, in the face of growing demand.
“We have seen the number of animals in our care grow; we are now caring for double the number of cats and dogs since the pandemic, many of whom need longer, more complex rehabilitation due to the nature of why they came into our care.
“Despite work to put the RSPCA on a more sustainable footing, between 2020 and 2024, the annual cost of rescuing and caring for animals has gone up by £17m, due to rising energy prices, veterinary costs, the increased need to pay for private boarding and the increase in the number of animals in our care.
"Alongside this, unforeseen costs such as the hike in national insurance, high inflation, rising fuel and increase in the cost of living, means it is a challenging climate for all charities, putting us under pressure at a time when donations are slowing across the sector.”
The RSPCA says it will continue to allocate log numbers for IET until the end of 2025 and vets have until the end of January 2026 to make any requests for payment in the usual way.
The awards celebrate the commitment and hard work of staff who support veterinary nursing students, recognising their talent, skill and dedication.
They're open to anyone involved in training and educating veterinary nurses in the UK, with the winners nominated by students and fellow professionals.
CQ Director Jacqui Garrett said: “We’re delighted to celebrate the Veterinary Nurse Educator of the Year Awards once again.
"The awards are a wonderful opportunity to shine a spotlight on the individuals who go above and beyond in training the next generation of veterinary nurses.
"I would encourage anyone who has been inspired by their tutor or colleague to submit a nomination and help us recognise their contribution to the veterinary nursing profession.”
The awards will be presented during the CQ Graduation and Awards Ceremony at Central Hall, Westminster, on Saturday, 28 March 2026, where there'll be a keynote speech from wildlife photographer and filmmaker, Gordon Buchanan.
Nominations close on Friday, 6 February.
Led by clinicians from Davies Veterinary Specialists, the Royal Veterinary College, and Willows Veterinary Centre and Referral Service, the study assessed the proportion of metronidazole use that was prescribed for non-antimicrobial purposes, and the rationale for it.
A survey was completed by 138 veterinarians, primarily in the UK and working in primary care small animal practice, who treated 332 cases (285 dogs and 47 cats) with metronidazole.
In 42% of cases, metronidazole was selected exclusively for non-antimicrobial targeted therapy, and was most commonly prescribed to treat acute diarrhoea, chronic diarrhoea, or giardiasis.
This, say researchers, is despite recommendations that antimicrobials are very rarely warranted for the management of acute and chronic diarrhoea.
The most common rationale cited by vets to justify metronidazole use was its supposed anti-inflammatory or immunomodulatory properties.
Other reasons included: treatment of suspected or confirmed anaerobic or susceptible bacterial infection, the patient being systemically unwell or having severe disease, treatment of protozoal infections, experiencing a previous positive outcome in a similar case or the same patient, anti-diarrhoeal action and owner or practice expectations.
Dr Justin Ng, lead author of the study, said: “These insights are alarming given that such practices frequently deviate from current antimicrobial use guidelines, potentially contributing to ongoing challenges with antimicrobial resistance and adverse effects on gastrointestinal health.”
https://onlinelibrary.wiley.com/doi/10.1111/jsap.13910
"Great Workplaces: Raising the Bar (Elevating Skills, Culture, and Leadership)" is a series of four in-depth conversations that will tackle themes that have an impact on recruitment and retention, uncovered through the Great Workplaces by BVA accreditation scheme.
All members of the profession are welcome to join the 50-minute webinar, which will be hosted by Rob Williams, BVA President, and Dr. Kirsten Ronngren, ManyPets Consulting Veterinarian & Vet Engagement Lead.
Rob said: “Effective mentorship is the backbone of any thriving veterinary workplace.
"Whether you’re guiding others or building your own skills, strong mentoring relationships can make all the difference.
"We hope colleagues find the webinars engaging and informative. In our first session, we’ll explore the power of mentoring and work through common gaps revealed by the Great Workplaces by BVA accreditation scheme.”
https://mybva.bva.co.uk/ems-event-calendar/mentoring-matters.html
The answers you get are all linked to their original sources in the BSAVA Library and website.
All BSAVA members get 25 free queries per month, whilst non-members get five.
Queries can also be bought in packs of 25, 50 and 100 searches which have no expiry, priced between £10 and £25 for members.
Alternatively, Rover Unleashed gives unlimited access.
Ian Mellor, Head of Publications at BSAVA said: “In a fast-paced clinical environment, we know that time is precious.
"Rover is a fantastic leap forward in how we support our members, combining innovation with reliability.
"All backed by our trusted resources, we’re confident that Rover will help you to easily cut through the noise and get straight to the information that matters.”
https://rover.bsava.com/pages/about
The company says that over that time, it has invested £122 million in sites, equipment and technology, but for some vets and nurses, a lack of training and confidence and a perceived lack of time has been a barrier to getting the most out of it.
The new CVS ‘Equipment Optimisation’ project will focus on CT, X-ray, dental X-ray, microscopy, endoscopy and laparoscopy, aiming to maximise its value and longevity.
The project plans to do this by helping to increase colleague confidence in the equipment’s ability, and to improve its maintenance - thereby reducing down time.
Each CVS practice will select one piece of equipment as a focus area for the next 12 months.
Each practice will create a plan, set project goals and then evaluate and share what works.
To support practices in their work, CVS has created a new clinical projects hub offering information and guidance on equipment set up, use, clinical interpretation, maintenance and troubleshooting.
The company is also offering additional training in the form of in-practice mentoring, radiation protection supervisor training, and a variety of online courses.
Lizzie McLennan Green, CVS Companion Animal UK Veterinary Director, said: “We’ve invested significantly in clinical equipment to improve patient diagnoses.
"And this project will help teams to feel confident in using and maintaining it.
"It offers a huge opportunity to continuously improve; offering better treatment and improved services to our clients and their animals.
“Each practice is being given the chance to select a piece of equipment that best fits their client base, their team and the way they work.
"We’re getting everyone involved from the start to tailor their own project – to make the process more targeted and meaningful.
“And to help colleagues, our clinical projects hub will be the go-to space containing all of the information, tools and support they need to get involved.
"It’ll also allow colleagues to connect with others, share ideas and build confidence as a wider team.”
PSS accredited practices are required to nominate an Appointed Senior Veterinary Surgeon, and under the RCVS Guidance, the College expects all veterinary service providers to do likewise.
Senior Veterinary Surgeons are responsible for making sure practice standards, policies and procedures are compliant with the Code and that legislation and guidance in areas such as veterinary medicines, consumer choice and professional autonomy are being met.
The new course outlines the roles and responsibilities of the appointed senior veterinary surgeon, with examples and scenarios drawn from the supporting guidance to the Code of Professional Conduct.
Clare Paget, RCVS Registrar and Director of Legal Services, said: “The role of appointed senior veterinary surgeon is an absolutely crucial one in the veterinary clinical practice setting.
"Having an appointed senior veterinary surgeon ensures that veterinary teams are working under the guidance and direction of a senior clinical figure and that there is someone who has overall accountability for standards at a practice.
"The appointed senior veterinary surgeon also has the important role of ensuring that the clinical judgement of the veterinary team is paramount over, for example, any commercial pressures.
“This course outlines the roles and responsibilities of the appointed senior veterinary surgeon and will help members of the vet team identify who they are within their organisation and, if relevant, recognise and implement the responsibilities of the role.”
The course takes around 30 minutes to complete, is free to access via the RCVS Academy, and counts towards annual continuing professional development (CPD) requirements for both veterinary surgeons and veterinary nurses.
academy.rcvs.org.uk
Anyone completing the BVRA Foundation Course will receive a joint BVRA/iPET Network Certificate of Achievement.
BVRA is also working on creating an Ofqual Regulated qualification in the sector, which will be available in the autumn 2023.
BVRA CEO, Kay Watson-Bray (pictured) said: “We have been listening to our members and their employers and identified the quality assurance that comes with regulation is a really important aspect of accredited CPD.
"This initiative will give veterinary receptionists the opportunity to gain an official qualification with transferable credits that they can use as a stepping stone to higher education and will provide a defined career path.”
The BVRA has also relaunched what was the Registered Veterinary Receptionist (RVR) as the new BVRA Associate Veterinary Receptionist (AVR).
Being an AVR gives BVRA members further membership benefits, training and status.
Kay added: “It’s an exciting time for veterinary receptionists who have previously had limited career path opportunities. BVRA is committed to provide the most up to date, relevant CPD created by industry experts.”
www.bvra.co.uk
To raise the funds, CVS put customer and staff collection boxes in its small animal first opinion practices and referral hospitals.
Staff also held a number of fundraising events – including sponsored walks and dog shows, as well as hosting Pet Blood Bank donation days.
The money raised from the partnership will help go towards funding Pet Blood Bank’s work.
Last year the charity sent over 5,000 units of blood to vets across the UK.
Pet Blood Bank provides training for vets and nurses, and donations also help the charity to keep the cost of blood products as low as possible, and provide them free to veterinary charities.
Deputy Chief Executive of CVS Group, Ben Jacklin, said: “Pet Blood Bank is a vital charity doing crucial work within our profession.
"There is no doubt that the level of funds raised is down to the tireless commitment shown by our colleagues up and down the country.
"I’d also like to recognise the role our clients have also made - as without them we would never have reached such a great total.”
Managing Director of Pet Blood Bank, Katrina Wilkinson said: “This generous donation from CVS Group has been incredible to receive.
"We are a small charity so need all the support we can get, and CVS has truly delivered."
CVS has recently announced its next charity partner as Guide Dogs for the Blind.
Skin diseases and palpable masses are a common presentation in guinea pigs brought for veterinary care2.
However, few studies have thus far looked at the prevalence of spontaneously arising diseases in pet guinea pigs.
"Lumpy bumpy guinea pigs: a retrospective study of 619 biopsy samples of externally palpable masses submitted from pet guinea pigs for histopathology" retrospectively analysed 619 biopsy samples submitted for histopathology from pet guinea pigs that had presented with externally palpable masses.
The purpose was to determine the most common tissue origins of these masses and the most frequent pathological diagnoses, together with signalment data for the most commonly diagnosed lesions.
Of the 619 samples submitted from 493 animals, 54 (8.7%) had arisen from the mammary glands3 and 15 (2.4%) from the thyroid glands, with the remaining 550 (88.9%) involving the skin and subcutis, muscle (n = 1), salivary glands (n = 4), lips (n = 2), ears (n = 4) and peripheral lymph nodes (n = 23).
Forty-seven (7.6%) of the masses were diagnosed as inflammatory in nature, including dermatitis, panniculitis, lymphadenitis, cheilitis, myositis, sialoadenitis, abscess and chronic inflammation with osseous metaplasia.
Non-neoplastic, non-inflammatory lesions accounted for a further 31 (5.0%), namely cysts, hamartomas, hyperplastic lesions, polyps, ectopic bone formation and salivary gland steatosis.
The remainder of the samples were neoplastic in nature (541; 87.4%), with 99 masses classified as epithelial in origin, 347 as mesenchymal, 23 as round cell, five as melanocytic and eight as unclassified malignant neoplasms.
Of these, mesenchymal neoplasms were further subdivided into benign (288) and malignant (59).
Lipomas were the most common neoplasm diagnosed, accounting for 286 of all samples submitted.
Of all 619 samples included in the study, the eight most commonly diagnosed lesions were lipoma (46.2%), trichofolliculoma (12.3%), sarcoma (of various subtypes: 9.5%), inflammation (all sites 7.6%), lymphoma / leukaemia (3.4%), mammary carcinoma (4%), mammary adenoma (3.2%) and thyroid carcinoma (1.5%).
Overall these eight diagnoses accounted for 87.7% of all submissions from the externally palpable masses from the pet guinea pigs submitted for histopathology.
Melanie said: “Guinea pigs are an increasingly popular household pet.
"Skin diseases, including palpable masses, are a common reason for veterinary presentation. But few studies have been published to date that provide information for clinicians about these conditions.
“This study illustrates the importance of neoplasms of the skin and subcutis in pet guinea pigs, with over 87% of the cases analysed having one of eight diagnoses.
"While most of these neoplasms are benign, a substantial minority are malignant and identifying those lesions is especially important in treatment planning.
"Clinicians dealing with pet guinea pigs should also be aware that some externally palpable masses may arise from the thyroid or mammary glands rather than the skin or subcutis, and that male guinea pigs may also develop mammary lesions.”
The paper has been selected as ‘Editor’s Choice’ by the Journal of Comparative Pathology and will be free to access until September on Lumpy, bumpy guinea pigs: a retrospective study of 619 biopsy samples of externally palpable masses submitted from pet guinea pigs for histopathology - ScienceDirect.
Miss Herdman faced three charges.
The first was that she indicated to a friend that she would supply diazepam and/or tramadol for use by their husband.
The second was that she supplied diazepam and/or tramadol and/or gabapentin.
The third was that she gave advice on the dosages of diazepam and/or tramadol and/or gabapentin.
Miss Herdman was not present at the hearing and was unrepresented, but the Committee determined that it was appropriate to proceed in her absence as she had been notified, was aware that the hearing was taking place and her absence was voluntary.
However, Miss Herdman had been in contact to indicate her pleas to the charges.
She admitted the intention to supply diazepam and/or tramadol and that she had provided advice on the dosages.
She also admitted that she had supplied diazepam but strongly denied that she had supplied tramadol and/or gabapentin.
Taking all the evidence into account (including messages sent by Miss Herdman and her admissions), the Committee found proven the charges in relation to the intent to supply and the advice on dosages.
The Committee also found proven the charge in relation to the supply of diazepam, but found not proved the charge relating to the supply of tramadol and gabapentin for several reasons, including the fact that the messages sent by Miss Herdman did not point unequivocally to her actually suppling each of the drugs to which she referred.
There was no suggestion that the diazepam was stolen from her place of work.
The Committee found that Miss Herdman’s actions had breached paragraphs 1.5 and 6.5 of the Code of Professional Conduct for Veterinary Nurses.
The committee judged that there were a number of aggravating features of Miss Herdman’s conduct, including that she was not qualified or authorised to prescribe medication to animals, let alone to human beings and that providing a controlled drug to a person who was already taking various painkilling medications was reckless.
The Committee also felt that a reasonable and informed member of the public would be very concerned to learn that a veterinary nurse had supplied a controlled drug to a friend for their personal use.
Regarding the sanction for Miss Herdman, Paul Morris, chairing the Veterinary Nursing Disciplinary Committee and speaking on its behalf, said: “Drawing all the material together, and considering the matter as a whole, the Committee had to impose a proportionate sanction for an isolated incident of serious professional misconduct which arose out of a misguided attempt to help a friend.
"The conduct in question was entirely out of keeping with Miss Herdman’s usual practice and there is no real risk that it will be repeated.
"However, this case was much too serious to take no further action and no useful purpose would be served by postponing a sanction.
“The Committee considered that a warning or reprimand would not be sufficient to satisfy the public interest as veterinary nurses are trusted by the public to deal with medication responsibly and failure to do constitutes a severe breach of trust.
“The Committee therefore considered a period of suspension sufficient to meet the public interest in maintaining the reputation of the profession and declaring and upholding proper standards of conduct for members of the profession.
“The Committee also considered whether a removal order would be appropriate but concluded it would be disproportionate and that such a step would remove from the profession an experienced, competent and valuable veterinary nurse for no discernible benefit.
“It was decided that Miss Herdman’s registration be suspended for a period of three months – a period which is sufficient to mark the gravity of the misconduct while taking into account the circumstances in which it arose.”
https://www.rcvs.org.uk/concerns/disciplinary-hearings/
The day will be led by Sonya Miles, BVSc CertAVP (ZM), CertAqV, MRCVS, RCVS Recognised Advanced Practitioner in Zoological Medicine and WAVMA Certified Aquatic Species Veterinarian.
Lectures will look at techniques, protocols, potential drug options and combinations as well as blood sampling and hospitalisation techniques in a wide variety of exotic species.
Delegates will also be provided with lecture notes, a CPD certificate, refreshments and lunch, as well as goodie bags provided by sponsors Pinmoore Animal Laboratory Services Limited.
Sonya says the aim of the day is to dispel many myths associated with anaesthetising a wide variety of exotic species, including fish and amphibians, whilst simultaneously providing vets and nurses with the skills to undertake these often challenging and comparatively high-risk anaesthetics.
To book your place or for more information, email: info@justexotics.co.uk or book online at https://justexoticsevents.co.uk/dont-miss-out-on-our-latest-event
Phovia, which was launched in the UK last year, is a two-part FLE system consisting of a chromophore gel that is applied to the affected skin and a blue light LED lamp.
Vetoquinol says that when used together they produce light of varying wavelengths that penetrates the skin to different depths, helping to control bacteria and reduce inflammation on the surface of the skin and stimulating regeneration in the epidermal and dermal layers.
The unit is portable, and applications take four minutes once a week.
The authors of the Vetoquinol-funded study say that FLE has already been shown to support and accelerate natural skin healing, but this latest research shows that the benefits go beyond improvement in clinical signs.
The study looked at 35 dogs with a diverse range of skin conditions: 13 had interdigital furunculosis, 10 had deep pyoderma, 6 had wounds, 4 had pyotraumatic dermatitis, and 2 had perianal fistula on presentation.
Eight of 35 dogs were new cases, whereas the remaining 27 were undergoing recrudescence of a prior episode, including pyotraumatic dermatitis, wounds, deep pyoderma, interdigital furunculosis and perianal fistulae.
Thirty dogs (86%) achieved a clinical resolution: 18 with the Fluorescent Light Energy alone and 12 with the concomitant use of FLE and topical antiseptic shampoo.
Five dogs (14%) had a partial response and needed other therapies.
92% percent of owners attested to their pet’s enhanced quality of life, with 74% of dogs displaying at least a 50% improvement in owner-reported behaviour, mood, sleep and playing activities.
The study also reported a 46% reduction in caregiver burden.
Felicity Caddick, Technical Services Manager at Vetoquinol said: “Managing skin conditions often requires the long-term use of shampoos or topical therapies.
"Many owners find this aspect of pet ownership challenging, especially with larger dogs, or less cooperative animals.
"FLE can reduce or in some cases eliminate the need for topical therapies at home, not only simplifying the treatment process but also enhancing convenience and compliance.
"Sharing responsibility for administering ongoing treatment with their vet practice also removes some of the worry associated with their pet’s health.”
Vetoquinol also highlights that Phovia can offer vets a drug-free management option for skin disorders that aligns with the principles of antibiotic stewardship.
Reference
The webinar will allow veterinary teams to learn from three expert speakers how they can make small practical changes to have positive impacts in their own settings.
Helen Ballantyne, Chair of the UK One Health Coordination Group (UKOHCG) and both a human and animal health nurse, will provide a ‘human’ view of One Health and the strategies in the NHS.
She will highlight areas of excellent practice she has experienced, and from a One Health angle where the veterinary profession could learn from the NHS, and vice versa.
Fergus Allerton MRCVS, an Internal Medicine Specialist and lead on antimicrobial resistance (AMR) at Linnaeus will talk about, amongst other things, the optimal use of antimicrobials for infection control.
In collaboration with the NHS, he launched Veterinary Antibiotic Amnesty activity which saw a 19% reduction of antimicrobial use across the Linnaeus veterinary group.
Fergus will also talk about the PROTECT ME guidelines on the responsible use of antibacterials, such as for surgical antibiotic prophylaxis.
Simon Doherty, past-president of the British Veterinary Association and one of two BVA representatives at the Federation of Veterinarians in Europe, will focus on the history of One Health and One Agriculture; highlighting how improved communication and collaboration at the intersection of people, animals and the environment can drive productivity and sustainability in food production.
Simon will also share some of Vet Sustain’s farm animal resources and how the principles can be applied.
To register, visit: https://horiba.link/one-health-webinar
The 'Lifelong Ear Partnership' resources, which were developed in conjunction with a panel of vets, are designed to help practice teams improve their owner communication and achieve owner buy-in about otitis.
To that end, Dechra has developed various owner communication tools for use in practice or to refer owners to after the consultation.
They include an owner website: www.ear-inflammation.co.uk and a postcard with QR code links to educational videos which cover clinical recommendations, treatment options and the importance of revisits.
There is also a brochure for owners and an online 4D ear model: www.4d-earmodel.com, which demonstrates a healthy ear and an ear with mild, moderate or severe otitis.
Finally, Dechra has also launched an ear cytology webinar series on Dechra Academy: www.dechra.co.uk/academy.
The course consists of tips for everything from greeting the patient to performing and interpreting cytology slides.
www.dechra.co.uk/otitis-externa.
New statistics from the Voice of the Veterinary Profession Spring 2022 survey showed that while veterinary work is often seen as a vocation, 77% of vets list pay among their top five priorities when choosing a job.
Other deciding factors include geographical location (74%), area of practice (62%), low staff turnover (45%) and structured career progression (28%).
However only 42% of vets who responded to the survey considered their pay and benefits to be either ‘good’, ‘very good’, or ‘excellent’.
BVA President Malcolm Morley, said: “Fair, transparent and equal pay is one of the keystones of good veterinary workplaces.
"Whether you’re an employee, a manager or an employer, it’s vital that everyone feels confident that their workplace approaches pay in a clear and consistent way.
"This isn’t about paying everyone more; it’s about using objective criteria and transparent pay scales to ensure the whole team understands how decisions about reward and recognition are made and what they can do to access higher pay.”
The new resource, created for BVA members as part of its Good Veterinary Workplaces campaign, includes information for veterinary employers on the benefits a clear pay structure can bring for the whole team.
It demonstrates the positive impact transparency around reward and recognition can have on employee fulfilment and retention, and outlines the legal requirements of employers to ensure that pay is equitable.
It also offers tips for employees and managers for approaching conversations about pay and emphasises the importance of considering ‘total reward’ during these conversations.
Total reward is the entire sum of a job’s offering including, but not limited to, salary, commission structure, benefits package, CPD, work/life balance, promotion opportunities, travel expenses, accommodation, and so on.
Malcolm added: “We know that pay can be a fraught, and even somewhat taboo, subject but it is one that we all have a responsibility to tackle if we want to ensure that veterinary professionals are fairly rewarded for their work.
"We hope that this new guide will support all our members and equip them with the knowledge required to ensure they can confidently navigate conversations about pay.”
https://www.bva.co.uk/talking-pay
The Linnaeus OAPC initiative was launched in 2021 and originally allocated £30K for 2022.
However, that figure was doubled after the company received a growing number of high quality submissions.
33 papers were accepted for funding in 2022, of which 24 have so far been published and the remainder are undergoing peer review.
The authors comprise clinicians, specialists, residents and interns across nine referral and primary care sites within the group.
The OAPC was introduced by Professor Luisa De Risio, Clinical Research & Excellence Director at Linnaeus (pictured right).
She said: “By making clinical research open access, we can ensure it makes the widest possible impact – while also supporting the author’s profile and career development.
"We are continuing to offer OAPC funding to our associates in 2023 and look forward to seeing the fantastic research published as a result.”
To ask Shelly a question, first read her article here: https://www.veterinary-practice.com/article/pain-management-for-veterinary-nurses
Then join the VetNurse Clinical Article Club here: https://www.vetnurse.co.uk/001/vetnurse-clinical-article-club
Then post your question or discuss the article in this thread: https://www.vetnurse.co.uk/001/vetnurse-clinical-article-club/f/clinical-article-club-discussions/32396/pain-management-for-veterinary-nurses
£50 for the post which provokes the most discussion by the end of the week!
Remember, all time spent reading or participating in Clinical Article Club discussions can be claimed towards your annual CPD requirement: Press 'Claim CPD' at the top of the discussion thread.
32% said they find dog care to be too restrictive
29% said it would be too difficult to go on holiday
24% said they don’t want to walk the dog every day and 25% that having a dog is too expensive.
41% of those who said they regret getting a dog bought it during lockdown.
Zoetis has announced a supply problem with Equip Artervac, its vaccine against equine viral arteritis
The current inventory of Equip Artervac has an expiry date of March 29, 2023 and the company is not expecting a new batch to be available until the end of September 2023.
Zoetis says it has been working with relevant organisations to implement a plan to mitigate the impact on breeders.
The Thoroughbred Breeders Association has published advice for a blood sampling scheme at: https://www.rossdales.com/news-events/tba-members-equine-vaccine-advice-regarding-disruption-to-supply-of-equip-artervac, but Zoetis highlights that the advice requires action two weeks after the most recent EVA vaccination.
For more information contact your Zoetis Account Manager or the Zoetis Technical Team on customersupportUK@zoetis.com or 0345 300 8034
The Association says it has produced the leaflet after seeing an increasing number of dogs diagnosed with clinical or subclinical infection, along with reports of its zoonotic impact.
The document outlines the most important considerations concerning B. canis including transmission, diagnosis, management, public health implications and legislative requirements.
It takes into consideration information available from relevant Government Departments.
BSAVA says the document is by no means exhaustive but is intended to provide useful information and signpost to further resources.
www.bsavalibrary.com/brucella_canis
Photo: Walker16/Wikipedia. CC BY-SA 4.0.
Membra is a transparent, water-resistant, non-toxic, biodegradable bandage replacement consisting of a hydrogel polymer which can be applied to open wounds.
It is initially applied as a liquid and quickly gels into a thin, flexible layer over the site.
The initial liquid phase of Membra allows it to cover open and irregular spaces as well as suture lines and it dries in minutes to form a barrier that covers and protects the incision site or wound.
Being transparent, Membra allows the wound to be seen by the veterinary team and pet owners.
Membra lasts for up to 14 days and naturally biodegrades over time.
Animus says that Membra lowers the risk of infection or dehiscence.
The company also says that hydrogel polymer has been shown to replace the need for adhesive bandaging on suture lines following major TPLO surgery.
A study concluded that the polymer did not appear to raise the prevalence of incisional complications after TPLO surgery and lasts for 14 days, rather than 24-48 hours with traditional bandaging1.
Nick Butcher MRCVS, owner of Animus Surgical in the UK, said: “Regular bandaging of open wounds can be costly, time-consuming and stressful for owners and their pets, requiring frequent visits to the practice.
"The bandaging of some open wounds can be impossible because of the location of the lesion or the affected species (e.g. exotic or aquatic animals) and more aggressive or nervous patients may require sedation.
"Used bandages also add to the volume of clinical waste generated by the practice which requires incineration
“We are therefore delighted to launch Membra to veterinary teams in the UK.
"It has been very successful in the U.S. and we already have a number of UK vets using the product as Membra can positively affect the outcome of open wound management across a range of species, without the need for regular bandage changes.”
To find out how to apply Membra, a range of YouTube videos are available showing a selection of case examples: https://youtube.com/@sutureseal5917.
www.animussurgical.com.